Background: Nonspecific colitis is an inflammatory Bowel Disease (IBD) that runs a clinically benign course. Histopathologically it is characterized by superficial mucosal erosions with lymphocytic infiltration in the lamina propria with no granuloma. Aim of this study: is to describe the clinical presentation of Non-Specific Colitis (NSC), and to evaluate its response to 5-aminosalicylic acid (5-ASA) in Sudanese patients.
he term indeterminate colitis (IC) is an interim, or preliminary descriptive term used by pathologists for cases of inflammatory bowel disease (IBD) in which a definite diagnosis of ulcerative colitis (UC) or Crohn's disease (CD) cannot be established. Most cases are due to fulminant ulcerative colitis, a condition in which the classic pathologic features of UC are often obscured and may overlap with CD 1 . The measurement of perinuclearantineutrophic cytoplasmic antibodies (P-ANCA) and antisaccharomyces cervisiae (ASCA) antibodies has been suggested as a method to differentiate UC form CD 2, 3 .The sensitivity of these tests is only 40-60%, limiting their usefulness in IC 3 .
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Methods

Thestudy was conducted in
). 
Discussion
There are no randomized clinical trials of medical therapy for IC. Assumptions have been made that patients with IC have a clinical course similar to UC and therefore medical therapy follows the approach one would use for UC. Therapy include 5-ASA suppositories and or topical steroids for proctitis and proctosigmoiditis 4 .
In 1978, Price introduced the term IC to refer to a subgroup of approximately 10-15% of IBS cases in which there was difficulty in distinguishing between UC and CD because the features of the typical severe UC were replaced by deep ulcer, relative rectal sparing and trasmural inflammation 5 . Typical CD fissuring type ulcerations were seen in 13% of cases of IC but the other histological feature of these IC cases reported so atypical that a diagnosis of CD could not be justified. The presence of scattered mononuclear inflammatory cells in the muscularis propria adjacent to ulceration was regarded as a nonspecific response and is not a discriminating feature between UC and CD. This nonspecific response could be due to a disease in mucosa caused by an organism that was not identified on routine stool culture 6 . The evaluation of IC is done by histological examination of colonic specimens. This was shown to carry inter-observer variation 7 . Another modality of evaluations is the use of upper GIT endoscopy to link gastroduodenitis caused by Helicobactorplori to both UC and CD especially in children [8] [9] [10] [11] [12] [13] . There is no clear definition of nonspecific colitis (NSC) in the literature. It is a term that is similar to indeterminate colitis (IC), in that it is between ulcerative colitis (UC) and CD 1 . The study showed that males are outnumbering the males (19 versus 7) and their age is clustering around 31 to 40 years (38.5%). Sixteen (61.6%) of the study group presented with bloody mucoid diarrhoea or a lower abdominal pain and (30.8.6%) 6/26 open their bowel at the night. These features are consistent with UC presentation 15 . During colonoscopy the rectum and sigmoid colon were found to be invariably in involved and in (38.5%) have tinny superficial ulcers that turned to have features of NSC in a pattern similar to colonic involvement in UC 16, 15 . 5-ASA is usually used to maintain the remission after controlling the acute attack of UC colitis 17. In this study it was used as oral medication to treat cases of NSC. All patients showed a good response. In conclusion NSC showed clinical features that are very much similar to mild UC with a fairly good clinical response to oral 5-ASA. A search for causative organisms should be made and a course of an oral corticosteriods followed by oral 5-ASA may be tried for treatment.
